TRACI ANN VOPALENSKY: Open Payments
NPI 1942855705 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,047 in 53 payments from 15 companies in 2025. Trend: 2023 $737 · 2024 $1,342 · 2025 $1,047
Food & beverage: $1,047
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $195 |
| SK Life Science, Inc. | 7 | $160 |
| Abbott Laboratories | 2 | $152 |
| Amneal Pharmaceuticals LLC | 12 | $151 |
| ABBVIE INC. | 4 | $84 |
| ACADIA Pharmaceuticals Inc | 4 | $68 |
| Lundbeck LLC | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Lilly USA, LLC | 2 | $32 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $25 |
Products named: OCTRODE, CREXONT, Nayzilam, NUPLAZID, Rystiggo, BOTOX, Zilbrysq, KESIMPTA.
Industry payments across AZ — which companies pay providers there.
